Connect Retained Earnings vs Good Will Analysis
| CNTB Stock | USD 1.55 0.12 8.39% |
Connect Biopharma financial indicator trend analysis is way more than just evaluating Connect Biopharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Connect Biopharma is a good investment. Please check the relationship between Connect Biopharma Retained Earnings and its Good Will accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Connect Biopharma Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Retained Earnings vs Good Will
Retained Earnings vs Good Will Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Connect Biopharma Retained Earnings account and Good Will. At this time, the significance of the direction appears to have no relationship.
The correlation between Connect Biopharma's Retained Earnings and Good Will is 0.02. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Good Will in the same time period over historical financial statements of Connect Biopharma Holdings, assuming nothing else is changed. The correlation between historical values of Connect Biopharma's Retained Earnings and Good Will is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Connect Biopharma Holdings are associated (or correlated) with its Good Will. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Good Will has no effect on the direction of Retained Earnings i.e., Connect Biopharma's Retained Earnings and Good Will go up and down completely randomly.
Correlation Coefficient | 0.02 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Most indicators from Connect Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Connect Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Connect Biopharma Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. At present, Connect Biopharma's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 0.27, whereas Tax Provision is forecasted to decline to about 114 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 4.1M | 6.9M | 988K | 938.6K | Total Operating Expenses | 621.5M | 785.2M | 64.8M | 61.6M |
Connect Biopharma fundamental ratios Correlations
Click cells to compare fundamentals
Connect Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Connect Biopharma fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Current Liab | 4.2M | 12.8M | 32.8M | 24.4M | 3.0M | 2.8M | |
| Total Current Liabilities | 27.4M | 38.0M | 114.7M | 108.8M | 24.3M | 23.1M | |
| Retained Earnings | (292.1M) | (1.1B) | (2.4B) | (3.2B) | (539.3M) | (566.3M) | |
| Accounts Payable | 22.8M | 24.6M | 81.2M | 83.1M | 7.7M | 7.3M | |
| Net Receivables | 1.2M | 1.7M | 47.3M | 1.6M | 178K | 169.1K | |
| Other Stockholder Equity | 42.5M | 48.1M | 4.2B | (71.2M) | 648.3M | 876.5M | |
| Total Current Assets | 362.8M | 1.1B | 1.8B | 1.1B | 121.0M | 114.9M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Connect Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Connect Biopharma's short interest history, or implied volatility extrapolated from Connect Biopharma options trading.
Pair Trading with Connect Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Connect Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Connect Stock
| 0.79 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
Moving against Connect Stock
| 0.59 | MBRX | Moleculin Biotech Financial Report 9th of May 2024 | PairCorr |
| 0.58 | GNLX | Genelux Common | PairCorr |
| 0.54 | LFCR | Lifecore Biomedical Financial Report 6th of June 2024 | PairCorr |
| 0.45 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
| 0.43 | ORGO | Organogenesis Holdings Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Connect Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Connect Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Connect Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Connect Biopharma Holdings to buy it.
The correlation of Connect Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Connect Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Connect Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Connect Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Connect Biopharma Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Connect Stock analysis
When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Connect Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Connect Biopharma. If investors know Connect will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Connect Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Return On Assets (0.27) | Return On Equity (0.46) |
The market value of Connect Biopharma is measured differently than its book value, which is the value of Connect that is recorded on the company's balance sheet. Investors also form their own opinion of Connect Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Connect Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Connect Biopharma's market value can be influenced by many factors that don't directly affect Connect Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Connect Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Connect Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Connect Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.